ecopipam has been researched along with sch 23390 in 7 studies
| Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (sch 23390) | Trials (sch 23390) | Recent Studies (post-2010) (sch 23390) |
|---|---|---|---|---|---|
| 147 | 18 | 34 | 803 | 0 | 585 |
| Protein | Taxonomy | ecopipam (IC50) | sch 23390 (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 1.0405 | |
| D | Rattus norvegicus (Norway rat) | 0.001 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.0461 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.0011 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0006 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.3891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gundertofte, K; Liljefors, T; Palm, J; Pettersson, I | 1 |
| Bøgesø, K; Liljefors, T; Pettersson, I | 1 |
| Berger, JG; Chang, WK; Chipkin, RE; Clader, JW; Hou, D; McPhail, AT | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Burnett, DA; Favreau, L; Fawzi, A; Greenlee, WJ; Lachowicz, JE; Smith, M; Spring, R; Wu, WL; Zhang, H | 1 |
| Burnett, DA; Fawzi, A; Greenlee, WJ; Lachowicz, JE; Mazzola, RD; McKittrick, BA; Qiang, L; Sasikumar, TK; Smith, M; Su, J; Tang, H; Ye, Y; Zhang, H; Zhu, Z | 1 |
| Begović, A; Castner, SA; Selemon, LD; Williams, GV | 1 |
1 review(s) available for ecopipam and sch 23390
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
6 other study(ies) available for ecopipam and sch 23390
| Article | Year |
|---|---|
A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Binding Sites; Electricity; Molecular Conformation; Receptors, Dopamine; Receptors, Dopamine D1; Structure-Activity Relationship | 1992 |
Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Chemical Phenomena; Chemistry, Physical; Dopamine Agents; Dopamine Antagonists; Molecular Conformation; Molecular Structure; Receptors, Dopamine; Receptors, Dopamine D1; Structure-Activity Relationship; Thermodynamics | 1990 |
Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
Topics: Animals; Benzazepines; Binding, Competitive; Chemical Phenomena; Chemistry; Dopamine Antagonists; In Vitro Techniques; Male; Models, Molecular; Molecular Conformation; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereoisomerism; Structure-Activity Relationship | 1989 |
Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.
Topics: Animals; Benzazepines; Cell Line; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Antagonists; Drug Design; Male; Models, Molecular; Phenols; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D5; Structure-Activity Relationship | 2005 |
Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists.
Topics: Animals; Benzazepines; Dopamine Antagonists; Rats; Receptors, Dopamine D1 | 2010 |
Reversal of neuronal and cognitive consequences of amphetamine sensitization following chronic treatment with a D1 antagonist.
Topics: Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Cognition; Dendrites; Dendritic Spines; Dopamine Antagonists; Female; Macaca mulatta; Male; Memory, Short-Term; Neurons; Psychomotor Performance; Receptors, Dopamine D1; RNA, Messenger; Signal Transduction | 2010 |